Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Transcriptomic Analysis of Peripheral Monocytes upon Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients — Giacomo Sferruzza (2021) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Transcriptomic Analysis of Peripheral Monocytes upon Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients
Shared by
Massimo Filippi
Transcriptomic Analysis of Peripheral Monocytes upon Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients
Article
2021
en
Authors
+11 more
GS
Giacomo Sferruzza
FC
Ferdinando Clarelli
EM
Elisabetta Mascia
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2022
Transcriptional Effects of Fingolimod Treatment on Peripheral T Cells in Relapsing Remitting Multiple Sclerosis Patients
Giacomo Sferruzza
,
Ferdinando Clarelli
,
Elisabetta Mascia
,
Laura Ferrè
,
Linda Ottoboni
,
Melissa Sorosina
,
Silvia Santoro
,
Massimo Filippi
,
Paolo Provero
,
Federica Esposito
Article
2022
Early use of fingolimod is associated with better clinical outcomes in relapsing–remitting multiple sclerosis patients
Miryam Cannizzaro
,
Laura Ferrè
,
Ferdinando Clarelli
,
Antonino Giordano
,
Francesca Sangalli
,
Bruno Colombo
,
Gıancarlo Comı
,
Lucia Moiola
,
Vittorio Martinelli
,
Massimo Filippi
,
Federica Esposito
Article
2023
Combining Clinical and Genetic Data to Predict Response to Fingolimod Treatment in Relapsing Remitting Multiple Sclerosis Patients: A Precision Medicine Approach
Laura Ferrè
,
Ferdinando Clarelli
,
Béatrice Pignolet
,
Elisabetta Mascia
,
Marco Frasca
,
Silvia Santoro
,
Melissa Sorosina
,
Florence Bucciarelli
,
Lucia Moiola
,
Vittorio Martinelli
,
Gıancarlo Comı
,
Roland Liblau
,
Massimo Filippi
,
Giorgio Valentini
,
Federica Esposito
Article
2024
Effects of fingolimod on focal and diffuse damage in patients with relapsing–remitting multiple sclerosis – The “EVOLUTION” study
Massimo Filippi
,
Elisabetta Pagani
,
Renato Turrini
,
Marta Bartezaghi
,
Vincenzo Brescia Morra
,
Giovanna Borriello
,
Valentina Torri Clerici
,
Massimiliano Mirabella
,
Livia Pasquali
,
Francesco Patti
,
Rocco Totaro
,
Paolo Gallo
,
Maria A. Rocca
Article
2020
Early evidence of disease activity during fingolimod predicts medium-term inefficacy in relapsing-remitting multiple sclerosis
Laura Ferrè
,
Andrea Mogavero
,
Ferdinando Clarelli
,
Lucia Moiola
,
Francesca Sangalli
,
Bruno Colombo
,
Vittorio Martinelli
,
Gıancarlo Comı
,
Massimo Filippi
,
Federica Esposito
Discussion(0)
No comments yet. Be the first to comment.